Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the PTEN gene in mice causes nerve cells to grow larger and heal better after injury, but may cause overgrowth and hair loss in older mice.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.

FOL-005 peptide may help treat excessive hair growth safely.

Akt2 protein is essential for normal cell division in early mouse embryos.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

Pyruvate Kinase M2 helps hair grow by linking energy production and a key hair growth pathway.

Normal human melanocytes can avoid cell death through multiple pathways.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Blocking mTORC1 reduces skin tumor growth in mice.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Progerin affects cell shape but not hair or skin in mice.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A new gene, mrp4, is found in mice and may play a unique role in hair follicle development in tails and ears.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

PAR-1 may play a role in hair growth regulation in human hair follicles.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.